- Home
- EYEN vs FORA Comparison
EYEN vs FORA Comparison
Compare EYEN & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- FORA
- Stock Information
- Founded
- EYEN 2014
- FORA 2014
- Country
- EYEN United States
- FORA United States
- Employees
- EYEN N/A
- FORA N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- EYEN Health Care
- FORA Technology
- Exchange
- EYEN Nasdaq
- FORA Nasdaq
- Market Cap
- EYEN 38.2M
- FORA 63.8M
- IPO Year
- EYEN 2018
- FORA N/A
- Fundamental
- Price
- EYEN $0.55
- FORA $2.10
- Analyst Decision
- EYEN Strong Buy
- FORA Strong Buy
- Analyst Count
- EYEN 2
- FORA 1
- Target Price
- EYEN $12.00
- FORA $5.00
- AVG Volume (30 Days)
- EYEN 879.0K
- FORA 14.2K
- Earning Date
- EYEN 11-11-2024
- FORA 11-07-2024
- Dividend Yield
- EYEN N/A
- FORA N/A
- EPS Growth
- EYEN N/A
- FORA N/A
- EPS
- EYEN N/A
- FORA 0.06
- Revenue
- EYEN $31,405.00
- FORA $20,371,880.00
- Revenue This Year
- EYEN $50,309.30
- FORA N/A
- Revenue Next Year
- EYEN $421.63
- FORA $10.64
- P/E Ratio
- EYEN N/A
- FORA $36.34
- Revenue Growth
- EYEN N/A
- FORA 6.97
- 52 Week Low
- EYEN $0.37
- FORA $2.00
- 52 Week High
- EYEN $2.57
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- EYEN 52.60
- FORA 38.13
- Support Level
- EYEN $0.52
- FORA $2.05
- Resistance Level
- EYEN $0.59
- FORA $2.16
- Average True Range (ATR)
- EYEN 0.05
- FORA 0.05
- MACD
- EYEN 0.01
- FORA 0.00
- Stochastic Oscillator
- EYEN 66.45
- FORA 31.77
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.